Feeds:
Posts
Comments

Search Results for 'CRISPR'

First single-course ‘curative’ CRISPR Shot by Intellia rivals Alnylam, Ionis and Pfizer

Posted in Biological Networks, Gene Regulation and Evolution, Cardiomyopathy, Cell Biology, Cerebrovascular and Neurodegenerative Diseases, Chemical Biology and its relations to Metabolic Disease, Chemical Genetics, CRISPR alternative for editing genes without cutting, CRISPR/Cas9 & Gene Editing, Frontiers in Cardiology and Cardiovascular Disorders, Genetics & Pharmaceutical, Genome Biology, Liver & Digestive Diseases Research, Population Health Management, Genetics & Pharmaceutical, Proteomics, RNA interference (RNAi) therapeutic, tagged on February 19, 2021| Leave a Comment »


First single-course ‘curative’ CRISPR Shot by Intellia rivals Alnylam, Ionis and Pfizer Reporter: Aviva Lev-Ari, PhD, RN   Intellia to kick-start first single-course ‘curative’ CRISPR shot, as it hopes to beat rivals Alnylam, Ionis and Pfizer by Ben Adams | Oct 19, 2020 10:39am It’s been a good year for Intellia: One of its founders, Jennifer Doudna, […]

Read Full Post »

Cancer treatment using CRISPR-based Genome Editing System

Posted in CRISPR/Cas9 & Gene Editing, Gene Therapy & Gene Editing Development, Genome Biology, tagged , , , on January 9, 2021| Leave a Comment »


Cancer treatment using CRISPR-based Genome Editing System  Reporter: Irina Robu, PhD CRISPR, stands for “clusters of regularly interspaced short palindromic repeats” is one of the biggest accomplishments in science of this decade and it is the simplest tool for altering DNA sequences and modifying gene functions. The technology is adapted form the natural defense mechanism […]

Read Full Post »

From AAAS Science News on COVID19: New CRISPR based diagnostic may shorten testing time to 5 minutes

Posted in Biomarkers: Inflammation, Cancer Researchers Fighting COVID-19, Coronavirus Gene Expression, COVID-19, COVID-19, COVID-19: Pandemic Surgery Guidance, CRISPR/Cas9 & Gene Editing, Population genetics, Population Health Management, Population Health Management, Genetics & Pharmaceutical, SAR-Cov-2 a vasculotropic (blood vessels) RNA Virus, SARS-CoV-2, Seasonality & Environmental Factors in Resurgence, Treatment Protocols for COVID-19, Virus Infective Acute Respiratory Syndrome: SARS-CoV, tagged , , , , , , , , , , , , on October 11, 2020| Leave a Comment »


From AAAS Science News on COVID19: New CRISPR based diagnostic may shorten testing time to 5 minutes Reporter: Stephen J. Williams, Ph.D.                   A new CRISPR-based diagnostic could shorten wait times for coronavirus tests.     New test detects coronavirus in just 5 minutes By Robert F. ServiceOct. […]

Read Full Post »

Prime Editing as a New CRISPR Tool to Enhance Precision and Versatility

Posted in CAR-T, CRISPR applied to Human Germ Line, CRISPR/Cas9 & Gene Editing, Disease Biology, Gene Therapy & Gene Editing Development, Genetics & Innovations in Treatment, Genome Biology, tagged , , , , , , , , , on August 29, 2020| 1 Comment »


Prime Editing as a New CRISPR Tool to Enhance Precision and Versatility   Reporter: Stephen J. Williams, PhD   CRISPR has become a powerful molecular for the editing of genomes tool in research, drug discovery, and the clinic (see posts and ebook on this site below) Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene […]

Read Full Post »

CRISPR-Cas9 and the Power of Butterfly Gene Editing

Posted in Behavioral Genetics, CRISPR alternative for editing genes without cutting, CRISPR/Cas9 & Gene Editing, Genome Biology, Microbiologial genetics, Transcriptomics on August 23, 2020| Leave a Comment »


CRISPR-Cas9 and the Power of Butterfly Gene Editing Reporter: Madison Davis Genome editing is a relatively new branch of genetic engineering that utilizes modern technologies in altering, inserting, or deleting selective DNA sequences within cells.  CRISPR-Cas9, otherwise known as “Clustered Regularly Interspaced Short Palindromic Repeat”, is a groundbreaking genome editing technique for scientists, as it […]

Read Full Post »

CRISPR companies calling for article retraction from Nature Methods – If the same or similar sequence of letters appears elsewhere in the genome, that can result in an unintentional or off-target edit – Concerns of Harm caused by Gene Editing using CRISPR-Cas9

Posted in CRISPR/Cas9 & Gene Editing on November 12, 2019| 2 Comments »


CRISPR companies calling for article retraction from Nature Methods – If the same or similar sequence of letters appears elsewhere in the genome, that can result in an unintentional or off-target edit – Concerns of Harm caused by Gene Editing using CRISPR-Cas9   Reporter: Aviva Lev-Ari, PhD, RN Storm around the call for “Nature Methods […]

Read Full Post »

CRISPR Cuts Turn Gels into Biological Watchdogs

Posted in CRISPR/Cas9 & Gene Editing, tagged , , , , on August 30, 2019| Leave a Comment »


Update 6/11/2020 CRISPR-IL used to develop next-gen genome editing products Haifa-based Pluristem Therapeutics is a regenerative medicine company that plans to develop next-generation multi-species genome editing products for human, plant and animal DNA that could improve work done in the pharma, agriculture and aquaculture industries. The CRISPR-IL consortium includes Sheba Medical Center and Schneider Children’s Medical […]

Read Full Post »

On July 19, 2019, Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office (USPTO) to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley (UC Berkeley).

Posted in Uncategorized on July 23, 2019| Leave a Comment »


Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office (USPTO) to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley (UC Berkeley). On Friday, July 19, Sigma-Aldrich submitted the request, available on blog PatentDocs, asking for a parallel interference to the one declared by the […]

Read Full Post »

At Technical University of Munich (TUM) Successful Genetical modification of a patient’s own immune cells, T cell receptors, using CRISPR-Cas9 gene editing tool. The engineered T cells are very similar to the physiological immune cells.

Posted in CRISPR/Cas9 & Gene Editing on July 17, 2019| Leave a Comment »


At Technical University of Munich (TUM) Successful Genetical modification of a patient’s own immune cells, T cell receptors, using CRISPR-Cas9 gene editing tool. The engineered T cells are very similar to the physiological immune cells. Reporter: Aviva Lev-Ari, PhD, RN   Targeted exchange using the CRISPR-Cas9 gene scissors The problem with conventional methods is that the […]

Read Full Post »

FIVE Forthcoming Books on CRISPR in 2019-2020: Flooded market or CRISPR-fatigued readers – Not to Worry !!!!!

Posted in CRISPR/Cas9 & Gene Editing on July 4, 2019| Leave a Comment »


FIVE Forthcoming Books on CRISPR in 2019-2020: Flooded market or CRISPR-fatigued readers – Not to Worry !!!!! Author: Aviva Lev-Ari, PhD, RN   From: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu> Date: Thursday, July 4, 2019 at 8:39 PM To: <damian.garde@statnews.com> Cc: Marcus W Feldman <mfeldman@stanford.edu>, “Stephen Williams, PhD” <sjwilliamspa@comcast.net>, Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>, Gail Thornton <gailsthornton@yahoo.com> Subject: Regarding your […]

Read Full Post »

Next »